Recently, CHAF1A has been associated with the development and progression of solid tumors, including breast cancer, prostate squamous cell carcinoma, hepatocellular carcinoma (HCC), glioma and neuroblastoma [39–43]. Here, CHAF1A is linked to hepatocellular carcinoma.